Variant phenotypes of incomplete achromatopsia in two cousins with GNAT2 gene mutations

Aarhus University, Aarhus, Central Jutland, Denmark
Investigative Ophthalmology &amp Visual Science (Impact Factor: 3.66). 12/2004; 45(12):4256-62. DOI: 10.1167/iovs.04-0317
Source: PubMed

ABSTRACT The present study was designed to elucidate the molecular genetic basis of a congenital stationary cone dysfunction characterized by congenital nystagmus, moderate visual impairment, and markedly disparate color vision deficiencies between two affected cousins.
Ophthalmic examinations with emphasis on color vision and electrophysiology. Molecular genetic analysis of the X-linked cone opsin genes, mutation screening of the CNGA3, CNGB3, and GNAT2 genes, and heterologous splicing experiments.
Whereas the proband was found to carry a homozygous frameshift mutation (Tyr95fs) in GNAT2, her cousin was compound heterozygous for the Tyr95fs and a new intronic mutation c.461 + 24G-->A. Heterologous expression in COS7 cells showed that the latter causes a splicing defect that results in early translation termination. Yet, this mutation is leaky, giving rise to small amounts of correctly spliced transcripts and offer an explanation for the diverging clinical findings in the cousins, one best described as incomplete achromatopsia and the other with oligocone trichromacy.
The cases presented broaden the phenotypic spectrum of GNAT2 mutations and underline the increasing importance of molecular genetics in the clinical diagnosis of atypical ophthalmic phenotypes.


Available from: Thomas Rosenberg, Jun 03, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Achromatopsia is an autosomal recessive inherited retinal disease caused by a complete loss of cone photoreceptor function. About 80 % of achromatopsia patients show mutations in the alpha or beta subunit (A3 and B3) of the cGMP controlled cation channel CNG (cyclic nucleotide-gated channel) of cone photoreceptors. Homologous to the human disease, CNGA3 deficient mice reveal a loss of cone specific functionality leading to degeneration of affected cone photoreceptors. The Institute for Ophthalmic Research in Tübingen has now succeeded in curing achromatopsia ACHM2 in an animal model. In this article, we explain the recombinant adeno-associated virus-based approach in detail. Furthermore, applied non-invasive diagnostic techniques for quality and success control, ERG, SLO and OCT, are described. The success of the therapy is indicated by a restored cone photoreceptor function as well as the neuronal processing of retinal signals resulting in a specific, cone-mediated behaviour. The outstanding results derived from the animal model are the starting point for the first human translation of a gene therapy for achromatopsia in Germany.
    Klinische Monatsblätter für Augenheilkunde 03/2014; 231(3):232-40. DOI:10.1055/s-0034-1368180 · 0.67 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A precise knowledge of the spectral sensitivities of the human cones is essential for the understanding and modeling of both normal and defective color vision. Here, we discuss cone spectral sensitivities, their relationship to color matching, and their derivation from psychophysical measurements obtained from normal trichromatic, dichromatic and monochromatic observers. We present a consistent set of mean 2-deg and 10-deg cone fundamentals based on the work of Stockman, Sharpe and Fach [1] and Stockman and Sharpe [2]. Along with the associated lens and macular pigment and photopigment templates, these can be used to model color vision at the cornea and retina and to account for individual differences. The common forms of congenital color vision deficiencies are due to alterations to the spectral sensitivities of the cones, or the loss of one or more cone photopigments. We consider these deficits, their symptoms and diagnosis.
    12/2007: pages 307-327;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Retinal neurodegeneration associated with the dysfunction or death of photoreceptors is a major cause of incurable vision loss. Tremendous progress has been made over the last two decades in discovering genes and genetic defects that lead to retinal diseases. The primary focus has now shifted to uncovering disease mechanisms and designing treatment strategies, especially inspired by the successful application of gene therapy in some forms of congenital blindness in humans. Both spontaneous and laboratory-generated mouse mutants have been valuable for providing fundamental insights into normal retinal development and for deciphering disease pathology. Here, we provide a review of mouse models of human retinal degeneration, with a primary focus on diseases affecting photoreceptor function. We also describe models associated with retinal pigment epithelium dysfunction or synaptic abnormalities. Furthermore, we highlight the crucial role of mouse models in elucidating retinal and photoreceptor biology in health and disease, and in the assessment of novel therapeutic modalities, including gene- and stem-cell-based therapies, for retinal degenerative diseases. © 2015. Published by The Company of Biologists Ltd.
    Disease Models and Mechanisms 02/2015; 8(2):109-129. DOI:10.1242/dmm.017913 · 5.54 Impact Factor